Evidence map›Paper›PMID 37223328›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2023

COVID-19 mortality in two waves of the pandemic in Cali, Colombia, before and during vaccination roll-out.

Carlos Reina, Pablo Roa, Anthony Garcés, Andrés Valencia, Miyerlandi Torres, Alberto Concha-Eastman

Abstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlos ReinaSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.
Pablo RoaSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.
Anthony GarcésSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.
Andrés ValenciaSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.
Miyerlandi TorresSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.
Alberto Concha-EastmanSecretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe the variation in COVID-19 mortality among residents of Cali, Colombia, in the second wave of the pandemic, before vaccines, and in the fourth wave, with vaccination roll-out in process, taking into account variables of sex, age group, comorbidities, and interval between onset of symptoms and death, and to estimate the number of deaths averted by vaccination. Methods: A cross-sectional study of second wave and fourth wave deaths and vaccination coverage. The frequencies of attributes of deceased population in the two waves were compared, including comorbidities. Machado's method was used to calculate an estimate of the number of deaths averted in the fourth wave. Results: There were 1 133 deaths in the second wave and 754 deaths in the fourth wave. It was calculated that approximately 3 763 deaths were averted in the fourth wave in Cali in the context of vaccination roll-out. Conclusions: The decline in COVID-19-associated mortality observed supports the continuation of the vaccination program. Given the lack of data to explain other possible reasons for this decline, such as on the severity of novel viral variants, the limitations of the study are discussed.

Indexed as

ColombiaCOVID-19COVID-19 vaccinesmortality

Identifiers

PMID37223328
PMCPMC10202339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.